ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676353; 2) Community: the network communities that were significantly associated with the response to NSC 676353; 3) Molecule: the relationships between components within communities and NSC 676353; 4) MDR: the compounds that were significantly associated with the NSC 676353.

NSC Compound Enrichment Correlation
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.00970780973624031 0.18556243
NSC 54044 N'-[1-(1-hydroxynaphthalen-2-yl)ethylidene]pyridine-4-carbohydrazide 0.00970780973624031 0.089323575
NSC 627506 Null 0.00970780973624031 0.1334856
NSC 635450 Null 0.00970780973624031 0.20487993
NSC 637126 Null 0.00970780973624031 -0.022104974
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00970780973624031 0.1193567
NSC 647328 Null 0.00970780973624031 0.26022301
NSC 665104 Null 0.00970780973624031 0.2331022
NSC 668254 Null 0.00970780973624031 0.32510142
NSC 672116 9-.alpha.-Acetoxyparthenolide 0.00970780973624031 0.18257116
Total:93  Current:21    [First] [Prev] [Next] [Last]